Healthequity, INC Form 4 insider transactions

HealthEquity's Founder and Vice Chairman, Stephen Neeleman, sold 570 shares of common stock to cover tax obligations related to vesting of shares.

HealthEquity's EVP & CFO, James M. Lucania, disposed of 1,848 shares of common stock on January 7, 2025, to cover tax obligations.

Delano Ladd, EVP and General Counsel at HealthEquity, sold 475 shares of common stock on January 7, 2025.

HealthEquity director Stuart B. Parker sold a total of 25,000 shares of common stock in multiple transactions on December 12, 2024.

Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., sold 2,869 shares of common stock at a price of $97.1193 per share on December 12, 2024.

Debra Charlotte McCowan, a director at HealthEquity, Inc., sold 5,000 shares of common stock on December 12, 2024.

A HealthEquity executive sold shares under a pre-arranged trading plan, with transactions occurring on December 9, 2024.

Frank Corvino, a former director of HealthEquity, Inc., sold 1,039 shares of common stock on November 6, 2024.

Director Robert Selander exercised stock options and sold shares of HealthEquity, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity Inc., reports a transaction involving common stock and derivative securities.

Delano Ladd, EVP and General Counsel of HealthEquity, Inc., reports the disposition of 617 shares of common stock to cover tax obligations.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity Inc., reports the disposition of 739 shares of common stock to cover tax obligations.

James Lucania, EVP & CFO of HealthEquity, Inc., disposed of 1,772 shares of common stock to cover tax obligations.

Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., reports the disposition of 2,456 shares of common stock to cover tax obligations.

Frank Corvino, a former director of HealthEquity, Inc., sold 1,247 shares of common stock on October 1, 2024, at a price of $80.2645 per share.

HealthEquity's CEO, Jon Kessler, executed multiple sales of common stock under a pre-arranged Rule 10b5-1 trading plan.

James Lucania, EVP & CFO of HealthEquity, Inc., disposed of 6,925 shares of common stock on September 10, 2024, to cover tax obligations.

Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc., sold 12,296 shares of common stock at a weighted average price of $77.0242 on September 6, 2024.

Stephen Neeleman, a Director and Officer of HealthEquity, Inc., executed stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Director Gayle Furgurson Wellborn exercised stock options and sold shares of HealthEquity, Inc. on July 9, 2024.

Former HealthEquity Inc. director Frank Corvino exercised stock options and sold shares on July 8, 2024.

Director Robert Selander reports acquisition of 2,543 common stock shares and holds 47,969 shares, along with stock options.

Director Evelyn S. Dilsaver reported the acquisition of 2,543 shares of HealthEquity, Inc. common stock and continued beneficial ownership of derivative securities.

Director Gayle Furgurson Wellborn acquired 2,543 shares of HealthEquity, Inc. common stock and holds stock options exercisable at $47.21 and $50.41.

Director Debra Charlotte McCowan reports acquiring 2,543 shares of HealthEquity, Inc. common stock on July 5, 2024, and now beneficially owns 12,779 shares.

Director Stuart B. Parker reports acquiring 2,543 shares of HealthEquity, Inc. common stock and disposing of an unspecified amount on July 5, 2024.

Director Paul Black reports acquisition and disposal of HealthEquity, Inc. common stock.

Rajesh Natarajan, a director of HealthEquity, Inc., acquired 2,543 restricted stock units on July 5, 2024, convertible to common stock, vesting on July 5, 2025, or the next annual stockholder meeting.

Director Adrian Dillon reported acquiring 2,543 shares of HealthEquity, Inc. common stock on July 5, 2024.

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, reports the disposition of shares to cover tax obligations and updates on holdings in trusts and options.